Mayinglong Pharmaceutical Group Co., Ltd.
SHH: 600993.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Youzhang Xia
- Employees
- 2,882
- Headquarters
- Wuhan, China
- IPO year
- 2004
- Market cap
- CN¥10.9B
- Website
- https://www.mayinglong.cn
Loading 600993…
Loading profile data…Frequently asked questions about 600993
What does Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) do?
Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, functional food, and Chinese medicine drink tablet products, as well as medical devices. The company also sells its products online. It also operates hospital...
Where does 600993.SS trade?
Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) trades on the Shanghai Stock Exchange.
What sector is 600993.SS in?
Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Mayinglong Pharmaceutical Group Co., Ltd.?
Youzhang Xia is the chief executive officer of Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS).
Where is Mayinglong Pharmaceutical Group Co., Ltd. headquartered?
Mayinglong Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 600993.SS pay a dividend?
Yes — Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) paid a trailing twelve-month dividend of CNY 0.62 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600993.SS go public?
Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) completed its initial public offering in 2004.